Naphthoquinone Analog-induced G1 Arrest is Mediated by cdc25A Inhibition and p53-independent p21 Induction in Human Hepatocarcinoma Cells

  • Kim, Won-Ho (Department of Biology, College of Natural Sciences, Chung-Ang University) ;
  • Kim, Jung-Woong (Department of Biology, College of Natural Sciences, Chung-Ang University) ;
  • Jang, Sang-Min (Department of Biology, College of Natural Sciences, Chung-Ang University) ;
  • Song, Ki-Hyun (Department of Biology, College of Natural Sciences, Chung-Ang University) ;
  • Ham, Seung-Wook (Department of Chemistry, College of Natural Sciences, Chung-Ang University) ;
  • Choi, Kyung-Hee (Department of Biology, College of Natural Sciences, Chung-Ang University)
  • Published : 2007.06.30

Abstract

The naphthoquinone analog (2,3-dichloro-6,9-dihydroxy-1,4-naphtoquinone, NA) has an inhibitory effect on cdc25A protein phosphatase in vitro, which is responsible for G1/S transition during cell cycle. However, the exact mechanism inducing the growth inhibition is not understood. In this study, we investigated the regulatory mechanisms of growth arrest induced by NA, as a new potent inhibitor of cdc25A phosphatase, in human hepatocarcinoma SK-hep-1 cells. We found that NA induced the G1 arrest by perturbation of protein tyrosine dephosphorylation of Cdk2, which may be resulting from inhibition of cdc25A phosphatase. In addition, p21 was expressed in a p53-independent manner and participated in the NA-induced G1 arrest by inhibiting Cdk2 activity. Although the exact mechanism is not known, the p21 expression might be related to MAPK activation. From these results, we suggest that NA induces G1 arrest via inhibition of cdc25A and induction of p53-independent p21 expression in SK-Hep-1 cells.

Keywords

References

  1. Brown PC, Dulik DM, and Jones TW (1991) The toxicity of menadione (2-methyl-1,4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial cells. Arch Biochem Biophys 285: 187-196 https://doi.org/10.1016/0003-9861(91)90348-M
  2. Chang L, and Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410: 37-40 https://doi.org/10.1038/35065000
  3. Chen S, and Gardner DG (2004) Suppression of WEE1 and stimulation of CDC25A correlates with endothelin-dependent proliferation of rat aortic smooth muscle cells. J Biol Chem 279: 13755-13763 https://doi.org/10.1074/jbc.M310064200
  4. Coulonval K, Bockstaele L, Paternot S, and Roger PP (2003) Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis. J Biol Chem 278: 52052-52060 https://doi.org/10.1074/jbc.M307012200
  5. Dobashi Y (2005) Cell cycle regulation and its aberrations in human lung carcinoma. Pathol Int 55: 95-105 https://doi.org/10.1111/j.1440-1827.2005.01799.x
  6. Dunkern TR, and Mueller KW (1999) Quantification of apoptosis induction by doxorubicin in three types of human mammary carcinoma spheroids. Anticancer Res 19: 3141-3146
  7. Esposito F, Russo L, Chirico G, Ammendola R, Russo T, and Cimino F (2001) Regulation of p21waf1/cip1 expression by intracellular redox conditions. IUBMB Life 52: 67-70 https://doi.org/10.1080/15216540252774793
  8. Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S, and Boiocchi M (1997) Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res 57: 2366-2368
  9. Ham SW, Park J, Lee SJ, Kim W, Kang K, and Choi KH (1998) Naphthoquinone analogs as inactivators of cdc25 phosphatase. Bioorg Med Chem Lett 8: 2507-2510 https://doi.org/10.1016/S0960-894X(98)00411-9
  10. Hashimoto O, Ueno T, Kimura R, Ohtsubo M, Nakamura T, Koga H, Torimura T, Uchida S, Yamashita K, and Sata M (2003) Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1. Mol Carcinog 36: 171-182 https://doi.org/10.1002/mc.10092
  11. Ito Y, Yoshida H, Uruno T, Takamura Y, Miya A, Kuma K, and Miyauchi A (2004) Expression of cdc25A and cdc25B phosphatase in breast carcinoma. Breast Cancer 11: 295-300 https://doi.org/10.1007/BF02984552
  12. Juan CC, and Wu FY (1993) Vitamin K3 inhibits growth of human hepatoma HepG2 cells by decreasing activities of both p34cdc2 kinase and phosphatase. Biochem Biophys Res Commun 190: 907-913 https://doi.org/10.1006/bbrc.1993.1135
  13. Kang KH, Kim WH, and Choi KH (1999) p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp Cell Res 253: 403-412 https://doi.org/10.1006/excr.1999.4644
  14. Kawabe T (2004) G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther 3: 513-519
  15. Kim YT, and Zhao M (2005) Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J 46: 597-613 https://doi.org/10.3349/ymj.2005.46.5.597
  16. Kim WH, Kang KH, Kim MY, and Choi KH (2000) Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells. Biochem Cell Biol 78: 127- 135 https://doi.org/10.1139/bcb-78-2-127
  17. Kleinberger DN, Shelah N, Capone R, Gazit A, and Levitzki A (1998) Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase. Exp Cell Res 241: 340-351 https://doi.org/10.1006/excr.1998.4061
  18. Markovits J, Sun TP, Juan CC, Ju GC, and Wu FY (1998) Menadione (vitamin K3) enhances the mitogenic signal of epidermal growth factor via extracellular signal-regulated kinases. Int J Oncol 13: 1163-1170
  19. Millar JB, McGowan CH, Lenaers G, Jones R, and Russell P (1991) p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. Embo J 10: 4301-4309
  20. Mitra J, and Enders GH (2004) Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene 23: 3361-3367 https://doi.org/10.1038/sj.onc.1207446
  21. Nilsson I, and Hoffmann I (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4: 107-114
  22. Nishikawa Y, Carr BI, Wang M, Kar S, Finn F, Dowd P, Zheng ZB, Kerns J, and Naganathan S (1995) Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem 270: 28304-28310 https://doi.org/10.1074/jbc.270.47.28304
  23. Nutter LM, Ngo EO, Fisher GR, and Gutierrez PL (1992) DNA strand scission and free radical production in menadionetreated cells. J Biol Chem 267: 2474-2479
  24. O'Connor PM (1997) Mammalian G1 and G2 phase checkpoints. Cancer Surv 29: 151-182
  25. Oh WJ, Kim WH, Kang KH, Kim TY, Kim MY, and Choi KH (1998) Induction of p21 during ceramide-mediated apoptosis in human hepatocarcinoma cells. Cancer Lett 129: 215-222 https://doi.org/10.1016/S0304-3835(98)00105-0
  26. Oztopcu P, Kabadere S, Mercangoz A, and Uyar R (2004) Comparison of vitamins K1, K2 and K3 effects on growth of rat glioma and human glioblastoma multiforme cells in vitro. Acta Neurol Belg 104: 106-110
  27. Robinson MJ, and Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186 https://doi.org/10.1016/S0955-0674(97)80061-0
  28. Sewing A, Wiseman B, Lloyd AC, and Land H (1997) Highintensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 17: 5588-5597 https://doi.org/10.1128/MCB.17.9.5588
  29. Sherr CJ, and Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163 https://doi.org/10.1101/gad.9.10.1149
  30. Vallee JN, Lo D, Guillevin R, Reb P, Adem C, and Chiras J (2003) In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents. J Vasc Interv Radiol 14: 621-628 https://doi.org/10.1097/01.RVI.0000064858.87207.B3
  31. Verweij J, Sparreboom A, and Nooter K (1999) Mitomycins. Cancer Chemother Biol Response Modif 18: 46-58
  32. Wang W, Takimoto R, Rastinejad F, and El-Deiry WS (2003) Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding. Mol Cell Biol 23: 2171-2181 https://doi.org/10.1128/MCB.23.6.2171-2181.2003
  33. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB, and Mercer WE (1995) p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/ macrophage differentiation. Cancer Res 55: 668-674